Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Serum HE4 as a prognostic marker in endometrial cancer--a population based study.

Brennan DJ, Hackethal A, Metcalf AM, Coward J, Ferguson K, Oehler MK, Quinn MA, Janda M, Leung Y, Freemantle M; ANECS Group, Webb PM, Spurdle AB, Obermair A.

Gynecol Oncol. 2014 Jan;132(1):159-65. doi: 10.1016/j.ygyno.2013.10.036. Epub 2013 Nov 6.

PMID:
24211402
2.

Improving identification of lynch syndrome patients: a comparison of research data with clinical records.

Tan YY, McGaughran J, Ferguson K, Walsh MD, Buchanan DD, Young JP, Webb PM, Obermair A, Spurdle AB; ANECS Group.

Int J Cancer. 2013 Jun 15;132(12):2876-83. doi: 10.1002/ijc.27978. Epub 2013 Jan 11.

3.

Genetic variants in ER cofactor genes and endometrial cancer risk.

Li Y, Low HQ, Foo JN, Darabi H, EinarsdĪŒttir K, Humphreys K, Spurdle A; ANECS Group, Easton DF, Thompson DJ, Dunning AM, Pharoah PD, Czene K, Chia KS, Hall P, Liu J.

PLoS One. 2012;7(8):e42445. doi: 10.1371/journal.pone.0042445. Epub 2012 Aug 2.

Supplemental Content

Loading ...
Support Center